China Dasheng Biotechnology Company Other Current Liabilities

China Dasheng Biotechnology Company posts a other current liabilities of $30K as of March 2026. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Other Current Liabilities is one piece of China Dasheng Biotechnology Company's financial statement story. At $30K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CDBT's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; China Dasheng Biotechnology Company's other metric pages and overview cover the third.